| Amount | Holding |
|---|---|
| 6.63% | Biogen Inc |
| 5.98% | Cigna Corp |
| 5.48% | Gilead Sciences Inc |
| 5.38% | Novo Nordisk A/S ADR |
| 5.28% | GlaxoSmithKline PLC ADR |
| 5.23% | Amgen Inc |
| 4.61% | Sanofi SA ADR |
| 4.43% | Cardinal Health Inc |
| 4.42% | Waters Corp |
| 4.34% | UnitedHealth Group Inc |
Expense Ratio Rating
4 /10
Expense Rating
0 /10
Market Score
2 /10
Category Score
0 /10
Market Size
2 /10
Expenses: 1.05% (Better than 0% of similar funds)
This is a bad choice for a Healthcare Sector Equity fund. See why ยป
| Amount | Holding |
|---|---|
| 6.63% | Biogen Inc |
| 5.98% | Cigna Corp |
| 5.48% | Gilead Sciences Inc |
| 5.38% | Novo Nordisk A/S ADR |
| 5.28% | GlaxoSmithKline PLC ADR |
| 5.23% | Amgen Inc |
| 4.61% | Sanofi SA ADR |
| 4.43% | Cardinal Health Inc |
| 4.42% | Waters Corp |
| 4.34% | UnitedHealth Group Inc |
Minafi - The intersection of FI, minimalism & mindfulness.
Don't miss out on new posts, courses, interactive articles and more!
Join & Get Your First Course Free© 2025 Adam Fortuna
Site Map